Name (Synonyms) | Correlation | |
---|---|---|
drug2957 | poractant alfa Wiki | 0.71 |
drug2612 | Usual Care Wiki | 0.32 |
Name (Synonyms) | Correlation | |
---|---|---|
D055371 | Acute Lung Injury NIH | 0.14 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.14 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.12 |
D013577 | Syndrome NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There are 2 clinical trials
This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.
Description: Time to bring down a fever (oral temperature < 37.2 ̊C)
Measure: Time to achieve afebrile Time: Change from baseline to 3rd and 7th-dayDescription: Symptoms diary card completed twice daily from Day 0 to Day 7
Measure: Severity of symptom score Time: Change from baseline to 3rd and 7th dayDescription: Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong
Measure: Patient reported improvement Time: Change from baseline to 3rd and 7th-dayDespite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.
Description: Number of participants with symptomatic, lab-confirmed COVID-19
Measure: Clinical confirmation of Covid-19 Time: From date of enrolment to 14 days